CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Raimondo Bruno

OPENALEX: A5009894617↗ORCID: 0000-0001-6673-833X↗

Affiliations

Organizations

Alcohol and Drug Foundationauthorship · AU Collaborative Research Groupauthorship · AU Core Laboratories (United States)authorship · US Sydney Local Health Districtauthorship · AU University of Tasmaniaauthorship · AU UNSW Sydneyauthorship · AU

Public evidence

6 connected articles

Changes in Drug-Induced Hospitalisations and Deaths During the First Year of the COVID-19 Pandemic in Australia.2025 · Europe PMC Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder.2022 · Europe PMC The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients.2021 · Europe PMC Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.2018 · Europe PMC Verbal Learning and Memory in Cannabis and Alcohol Users: An Event-Related Potential Investigation.2017 · PubMed Central Open Access Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form.2016 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Raimondo Bruno - Medical Cannabis Research Engine